Your Source for Venture Capital and Private Equity Financings

VC-funded Company:

Korro Bio
One Kendall Square
Building 600-700 Suite 6-401
Cambridge, MA 02139
Phone: 617-468-1999
https://www.korrobio.com/

Korro is an RNA editing company focused on discovery and development of a new class of precision genetic medicines. Korro's proprietary and modular platform, OPERA, combines data-driven design with off-the-shelf chemistry and delivery to achieve highly selective RNA editing.

Key Contact
Name
Ram Aiyar
Title
CEO
E-Mail
Funding Events

Date
Amount
Type
Investors
Valuation
01/05/22 $116,000,000 Series B Alexandria Venture Investments
Atlas Venture
Cormorant Asset Management
Eventide Asset Management
Fidelity Management & Research Company
Invus
Monashee Investment Management
New Enterprise Associates
Point72 Ventures
Sixty Degree Capital
Surveyor Capital
Verition Fund Management
undisclosed